Cargando…
A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye
The autoimmune disorder, Sjögren’s syndrome (SS), is characterized by lymphocytic infiltration and loss of function of exocrine glands such as the lacrimal gland (LG) and salivary gland. SS-associated changes in the LG are associated with the development of autoimmune-mediated dry eye disease. We ha...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216292/ https://www.ncbi.nlm.nih.gov/pubmed/32326657 http://dx.doi.org/10.3390/ijms21082758 |
_version_ | 1783532385558593536 |
---|---|
author | Hsueh, Pang-Yu Ju, Yaping Vega, Adrianna Edman, Maria C. MacKay, J. Andrew Hamm-Alvarez, Sarah F. |
author_facet | Hsueh, Pang-Yu Ju, Yaping Vega, Adrianna Edman, Maria C. MacKay, J. Andrew Hamm-Alvarez, Sarah F. |
author_sort | Hsueh, Pang-Yu |
collection | PubMed |
description | The autoimmune disorder, Sjögren’s syndrome (SS), is characterized by lymphocytic infiltration and loss of function of exocrine glands such as the lacrimal gland (LG) and salivary gland. SS-associated changes in the LG are associated with the development of autoimmune-mediated dry eye disease. We have previously reported the accumulation of intercellular adhesion molecule 1 (ICAM-1) in the LG of Non-Obese Diabetic (NOD) mice, a murine model of autoimmune-mediated dry eye in SS, in both LG acinar cells and infiltrating lymphocytes. ICAM-1 initiates T-cell activation and can trigger T-cell migration through binding to lymphocyte function-associated 1 antigen (LFA). To modulate this interaction, this study introduces a new tool, a multivalent biopolymeric nanoparticle assembled from a diblock elastin-like polypeptide (ELP) using the S48I48 (SI) ELP scaffold fused with a mouse ICAM-1 targeting peptide to form IBP-SI. IBP-SI forms a multivalent, monodisperse nanoparticle with a radius of 21.9 nm. Unlike the parent SI, IBP-SI binds mouse ICAM-1 and is internalized by endocytosis into transfected HeLa cells before it accumulates in lysosomes. In vitro assays measuring lymphocyte adhesion to Tumor Necrosis Factor TNF-α-treated bEnd.3 cells, which express high levels of ICAM-1, show that adhesion is inhibited by IBP-SI but not by SI, with IC(50) values of 62.7 μM and 81.2 μM, respectively, in two different assay formats. IBP-SI, but not SI, also blocked T-cell proliferation in a mixed lymphocyte reaction by 74% relative to proliferation in an untreated mixed cell reaction. These data suggest that a biopolymeric nanoparticle with affinity for ICAM-1 can disrupt ICAM-1 and LFA interactions in vitro and may have further utility as an in vivo tool or potential therapeutic. |
format | Online Article Text |
id | pubmed-7216292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72162922020-05-22 A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye Hsueh, Pang-Yu Ju, Yaping Vega, Adrianna Edman, Maria C. MacKay, J. Andrew Hamm-Alvarez, Sarah F. Int J Mol Sci Article The autoimmune disorder, Sjögren’s syndrome (SS), is characterized by lymphocytic infiltration and loss of function of exocrine glands such as the lacrimal gland (LG) and salivary gland. SS-associated changes in the LG are associated with the development of autoimmune-mediated dry eye disease. We have previously reported the accumulation of intercellular adhesion molecule 1 (ICAM-1) in the LG of Non-Obese Diabetic (NOD) mice, a murine model of autoimmune-mediated dry eye in SS, in both LG acinar cells and infiltrating lymphocytes. ICAM-1 initiates T-cell activation and can trigger T-cell migration through binding to lymphocyte function-associated 1 antigen (LFA). To modulate this interaction, this study introduces a new tool, a multivalent biopolymeric nanoparticle assembled from a diblock elastin-like polypeptide (ELP) using the S48I48 (SI) ELP scaffold fused with a mouse ICAM-1 targeting peptide to form IBP-SI. IBP-SI forms a multivalent, monodisperse nanoparticle with a radius of 21.9 nm. Unlike the parent SI, IBP-SI binds mouse ICAM-1 and is internalized by endocytosis into transfected HeLa cells before it accumulates in lysosomes. In vitro assays measuring lymphocyte adhesion to Tumor Necrosis Factor TNF-α-treated bEnd.3 cells, which express high levels of ICAM-1, show that adhesion is inhibited by IBP-SI but not by SI, with IC(50) values of 62.7 μM and 81.2 μM, respectively, in two different assay formats. IBP-SI, but not SI, also blocked T-cell proliferation in a mixed lymphocyte reaction by 74% relative to proliferation in an untreated mixed cell reaction. These data suggest that a biopolymeric nanoparticle with affinity for ICAM-1 can disrupt ICAM-1 and LFA interactions in vitro and may have further utility as an in vivo tool or potential therapeutic. MDPI 2020-04-15 /pmc/articles/PMC7216292/ /pubmed/32326657 http://dx.doi.org/10.3390/ijms21082758 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hsueh, Pang-Yu Ju, Yaping Vega, Adrianna Edman, Maria C. MacKay, J. Andrew Hamm-Alvarez, Sarah F. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye |
title | A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye |
title_full | A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye |
title_fullStr | A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye |
title_full_unstemmed | A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye |
title_short | A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye |
title_sort | multivalent icam-1 binding nanoparticle which inhibits icam-1 and lfa-1 interaction represents a new tool for the investigation of autoimmune-mediated dry eye |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216292/ https://www.ncbi.nlm.nih.gov/pubmed/32326657 http://dx.doi.org/10.3390/ijms21082758 |
work_keys_str_mv | AT hsuehpangyu amultivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT juyaping amultivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT vegaadrianna amultivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT edmanmariac amultivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT mackayjandrew amultivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT hammalvarezsarahf amultivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT hsuehpangyu multivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT juyaping multivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT vegaadrianna multivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT edmanmariac multivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT mackayjandrew multivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye AT hammalvarezsarahf multivalenticam1bindingnanoparticlewhichinhibitsicam1andlfa1interactionrepresentsanewtoolfortheinvestigationofautoimmunemediateddryeye |